| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.044 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.071 | 0.8 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.036 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |